Stockreport

Century Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Updates [Yahoo! Finance]

Century Therapeutics, Inc.  (IPSC) 
PDF – Presented interim results from Phase 1 ELiPSE-1 trial of CNTY-101 demonstrating encouraging preliminary efficacy and tolerability data in heavily pretreated relapsed/ [Read more]